1. Home
  2. MPV vs QNCX Comparison

MPV vs QNCX Comparison

Compare MPV & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Barings Participation Investors

MPV

Barings Participation Investors

N/A

Current Price

$19.08

Market Cap

201.1M

Sector

Finance

ML Signal

N/A

Logo Quince Therapeutics Inc.

QNCX

Quince Therapeutics Inc.

N/A

Current Price

$0.10

Market Cap

167.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MPV
QNCX
Founded
1988
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
201.1M
167.0M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
MPV
QNCX
Price
$19.08
$0.10
Analyst Decision
Hold
Analyst Count
0
3
Target Price
N/A
$10.00
AVG Volume (30 Days)
9.5K
67.7M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
8.71%
N/A
EPS Growth
N/A
N/A
EPS
1.71
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$11.23
N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.22
$0.09
52 Week High
$21.00
$4.55

Technical Indicators

Market Signals
Indicator
MPV
QNCX
Relative Strength Index (RSI) 52.59 27.94
Support Level $18.64 $0.09
Resistance Level $19.54 $0.98
Average True Range (ATR) 0.34 0.02
MACD 0.01 0.09
Stochastic Oscillator 78.95 21.43

Price Performance

Historical Comparison
MPV
QNCX

About MPV Barings Participation Investors

Barings Participation Investors is a diversified closed-ended management investment company. The Trust's investment objective is to maintain a portfolio of securities providing a current yield and an opportunity for capital gains. Its principal investments are privately placed, below-investment grade, long-term debt obligations including bank loans and mezzanine debt instruments. The company invests in various sectors such as aerospace and defense; automotive; building materials; consumer products and others.

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.

Share on Social Networks: